Blood Pressure Assessment in Atrial Fibrillation

Evaluation of the Oscillometric Blood Pressure Measurement in Atrial Fibrillation and Relation of Blood Pressure With Serum Biomarkers and Echocardiographic Indexes

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01088269

Enrollment

100

Registered

2010-03-17

Start date

2010-03-31

Completion date

2017-12-31

Last updated

2017-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Blood Pressure Measurement, Atrial Fibrillation, Blood pressure measurement in atrial fibrillation, Atrial Fibrillation diagnosis

Brief summary

This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include: * clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric device) * 24-hour ambulatory blood pressure monitoring * determination of various serum markers and cardiac ultrasound. * evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

25 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Hypertensives adults in atrial fibrillation

Exclusion criteria

* Renal disease (Cr \> 2 mg/l). * Patients with pacemaker rhythm during the study. * Each patient with acute disease (inflammation, surgery), malignancy, collagen diseases, pulmonary fibrosis, renal failure, liver failure, chronic inflammatory diseases.

Design outcomes

Primary

Measure	Time frame	Description
Blood Pressure Measurement in Atrial Fibrillation,Serum Markers and echocardiographic indexes in atrial fibrillation (AF)	Baseline	1. Evaluation of the oscillometric technique of an electronic device in blood pressure measurement. 2. Evaluation of the relationship of blood pressure levels with serum markers and ultrasonographic cardiac indexes. 3. Evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG

Countries

Greece

Contacts

Primary ContactGeorge S Stergiou, MD

gstergi@med.uoa.gr+302107763117

Outcome results